Boston Scientific Loses First Federal Trial Over Mesh

Updated on

Boston Scientific Corp. must pay $26.7 million to a group of four women who blamed the company’s vaginal inserts for injuring them, a jury concluded in the first federal trial of claims over the devices.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.